<scp>NKG2A</scp>‐checkpoint inhibition and its blockade critically depends on peptides presented by its ligand<scp>HLA‐E</scp>-Reference-Cited by-同舟云学术

NKG2A‐checkpoint inhibition and its blockade critically depends on peptides presented by its ligandHLA‐E

Published:2022-06-06 Issue:4 Volume:166 Page:507-521
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Battin Claire¹^ORCID,Kaufmann Gabriel¹,Leitner Judith¹^ORCID,Tobias Joshua²^ORCID,Wiedermann Ursula²^ORCID,Rölle Alexander³⁴,Meyer Marten³⁵,Momburg Frank³⁵^ORCID,Steinberger Peter¹^ORCID

Affiliation:

1. Division of Immune Receptors and T Cell Activation, Center for Pathophysiology, Infectiology and Immunology Medical University of Vienna Vienna Austria

2. Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology Medical University of Vienna Vienna Austria

3. Clinical Cooperation Unit “Applied Tumor Immunity” German Cancer Research Center Heidelberg Germany

4. Department of Medical Oncology, National Center for Tumor Diseases University Hospital Heidelberg Heidelberg Germany

5. Antigen Presentation and T/NK Cell Activation Group DKFZ Heidelberg Germany

Funder

Austrian Science Fund

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13515

Reference41 articles.